Health Organization in Dubai grants permission for Yas Healthcare to establish the nation's first Proton Therapy Facility.
The UAE's first-ever proton therapy centre is about to call Dubai home, thanks to the Dubai Health Authority's approval of Yas Healthcare, a Das Holding subsidiary's, pioneering project.
This groundbreaking facility, set to break ground in early 2026 and open its doors by 2028, promises a major leap forward in the country's cancer combat efforts.
The Yas Proton Therapy Centre is poised to introduce one of the most advanced cancer treatments to the region. Proton therapy, a precise method of irradiating tumors, significantly reduces damage to adjacent healthy tissue, making it ideal for paediatric cancers and tumors near vital organs.
According to Dr. Alawi Alsheikh-Ali, DHA's Director-General, the project aligns perfectly with Dubai's long-term health strategies, including the Dubai Economic Agenda D33 and the National Strategy for Wellbeing 2031.
Partnering with the National Cancer Centre Singapore (NCCS), a global leader in oncology, the project stands to gain from the collective clinical and technical expertise of these institutions. In fact, the NCCS will serve as the project's consultant throughout the design and implementation phases.
Dr. Mohamad Zaki of Yas Healthcare underscored the mounting need for such treatment, pointing to rising cancer rates and the advantages of proton therapy in cutting down on long-term side effects.
Once in operation, the centre would eliminate the necessity for regional patients to travel overseas for specialized care. This move not only supports Dubai's medical tourism aspirations but also improves GCC residents' access to top-tier cancer treatment.
Needless to say, the Yas Proton Therapy Centre will fundamentally revamp cancer care in the region. This health revolution will enable local residents while bolstering Dubai's global standing as a medical tourism hub.
Aside from enhancing cancer care in the UAE, the centre is expected to begin construction early next year, with the goal of completing it by late 2028[1][2]. The benefits of this advanced technology include its precision in targeting cancer cells and minimizing collateral damage to healthy tissue[1][2]. This technology is particularly useful for treating tumors near critical structures without causing significant harm, resulting in better patient outcomes and reduced side effects[1][2]. The collaboration with the National Cancer Centre Singapore aims to enrich the quality of cancer care in the UAE and provide local patients with access to advanced treatments[2]. Upon its opening, the centre is anticipated to attract more international patients seeking specialized care, contributing to the growth of Dubai's healthcare sector and Dubai's reputation as a hub for medical tourism[1][2].
News Source: Emirates News Agency
- The collaboration with the National Cancer Centre Singapore (NCCS) will bring valuable clinical and technical expertise to the Yas Proton Therapy Centre, contributing to its innovation in cancer treatment.
- The advancement in health and wellness through the Yas Proton Therapy Centre aligns with Dubai's long-term strategies, such as Dubai Economic Agenda D33 and the National Strategy for Wellbeing 2031.
- With the opening of the Yas Proton Therapy Centre, cancer patients in the region will have access to a more advanced treatment method, reducing long-term side effects and improving outcomes.
- The focus on health, particularly cancer treatment, through the Yas Proton Therapy Centre aligns with the UAE's tourism strategy, as it attracts international patients seeking specialized care and supports Dubai's medical tourism aspirations.
